Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Licenses Johns Hopkins Cancer IP for Dx Development

NEW YORK (GenomeWeb News) — Beckman Coulter has inked two deals with Johns Hopkins University for exclusive licenses to intellectual property tied to cancer genomics research, the company said today.
 
Terms of the agreements give Beckman Coulter the “exclusive option to license any of the genetic mutations discovered in these studies that have diagnostic potential,” Bruce Wallace, vice president of Beckman Coulter's Molecular Diagnostics Business Center, said in a statement.
 
The first agreement covers 200 genes that have been linked to breast and colon cancer that were discovered in a study at the Johns Hopkins Kimmel Cancer Center.
 
The other agreement is for sequencing services and options to license genomic IP related to six additional cancers.
  
Beckman Coulter’s molecular diagnostics assay group is already evaluating the breast and colon cancer genes. “The success of our strategic plan is dependent in part on our development of a robust molecular diagnostics business.”
 
He said the company is “already in the process of moving our research genomics technologies into platforms for diagnostic use. Building content, or approved tests for that platform, from research such as the John Hopkins cancer genomics studies, will enhance our success.”
 
Financial terms of the agreements were not released.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.